• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. OncoMed says CMO Dupont has resigned and expects return to Genentech/Roche

    OncoMed says CMO Dupont has resigned and expects return to Genentech/Roche

  2. Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared to Rituxan

    Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared to Rituxan

  3. One-Stop Shopping for Exposure to International Stocks

    This iShares’ ETF has appeal, but investors don't have to go much further afield to find more-compelling options.

  4. New Cancer Drugs: First Movers Will Win

    First movers, including Bristol-Myers, and firms that can aggregate a portfolio of immuno-oncology therapies will be positioned well.

  5. Wide-Moat Funds That Fly Under the Radar

    These quality funds with smaller asset bases have portfolios built around solid companies.

  6. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

  7. Dodge & Cox: Pharma Stocks Showing Value

    As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.